Home

Andrew Cheng, President and CEO: Akero Therapeutics AKRO Sell · Filed 25/09/12

Trade details

Type
Insider sale
Amount
$321,948
Shares · price
7,317 sh · $44.00 a share
Held after
475,856 sh
Trade date
25/09/10
Filed
25/09/12
Days to filing
2 days

Sold 1.5% of holdings

Share of holding sold
1.5%

Akero Therapeutics trades, last 26 weeks

What else happened in Akero Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/11~25/10/10

Andrew Cheng's recent trades

  • Andrew Cheng

    Sell10b5-1 planAkero Therapeutics

    $1.6M

    Filed 25/10/14

  • Andrew Cheng

    Sell10b5-1 planAkero Therapeutics

    $968.3K

    Filed 25/09/12

  • Andrew Cheng

    Sell10b5-1 planAkero Therapeutics

    $77.3K

    Filed 25/09/12

  • Andrew Cheng

    Sell10b5-1 planAkero Therapeutics

    $7,050

    Filed 25/09/12

  • Andrew Cheng

    Sell10b5-1 planAkero Therapeutics

    $919K

    Filed 25/08/13

Andrew Cheng, CEO — sold $321.9K of Akero Therapeutics AKRO · 1.5% of holdings · 10b5-1 plan | Whalegun